Zachary Roberts
Chief Tech/Sci/R&D Officer chez ALLOGENE THERAPEUTICS, INC.
Fortune : 2 M $ au 31/03/2024
Profil
Zachary Roberts is currently the Chief Medical Officer & Executive Vice President at Allogene Therapeutics, Inc. He previously worked as the Director-Clinical Medical Research at Amgen, Inc. in 2015, the Vice President-Clinical Development at Kite Pharma, Inc. from 2018 to 2019, and the Chief Medical Officer at Instil Bio, Inc. from 2020 to 2022.
Dr. Roberts obtained his undergraduate degree from the University of Maryland and his doctorate from the University of Maryland School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/01/2024 | 515 253 ( 0,30% ) | 2 M $ | 31/03/2024 |
Postes actifs de Zachary Roberts
| Sociétés | Poste | Début |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 03/01/2023 |
Anciens postes connus de Zachary Roberts
| Sociétés | Poste | Fin |
|---|---|---|
| INSTIL BIO, INC. | Chief Tech/Sci/R&D Officer | 11/11/2022 |
| KITE PHARMA INC | Chief Tech/Sci/R&D Officer | 01/05/2019 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 01/07/2015 |
Formation de Zachary Roberts
| University of Maryland | Undergraduate Degree |
| University of Maryland School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| ALLOGENE THERAPEUTICS, INC. | Health Technology |
| INSTIL BIO, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
